These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12079889)

  • 21. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.
    Pugliese A; Zeller M; Fernandez A; Zalcberg LJ; Bartlett RJ; Ricordi C; Pietropaolo M; Eisenbarth GS; Bennett ST; Patel DD
    Nat Genet; 1997 Mar; 15(3):293-7. PubMed ID: 9054945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
    Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
    Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dense mapping of the region of insulin gene VNTR in polycystic ovary syndrome in a population of women from Central Europe.
    Attaoua R; Boeckler N; Radian S; Ait El Mkadem S; Poucheret P; Latapie V; Gheorghiu M; Fica S; Vintila M; Normand C; Coculescu M; Grigorescu F
    Endokrynol Pol; 2015; 66(3):198-206. PubMed ID: 26136127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype.
    Urbanek M; Sam S; Legro RS; Dunaif A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4191-8. PubMed ID: 17785364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association of INS VNTR polymorphism with polycystic ovary syndrome: a meta-analysis.
    Song LY; Luo JR; Peng QL; Wang J; Xie L; He Y; Li S; Qin X
    J Assist Reprod Genet; 2014 Jun; 31(6):675-81. PubMed ID: 24677210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic determinants of insulin action in polycystic ovary syndrome.
    Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased prevalence of VNTR III of the insulin gene in women with gestational diabetes mellitus (GDM).
    Litou H; Anastasiou E; Thalassinou L; Sarika HL; Philippou G; Alevizaki M
    Diabetes Res Clin Pract; 2007 May; 76(2):223-8. PubMed ID: 17011062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.
    Marioli DJ; Koika V; Adonakis GL; Saltamavros AD; Karela A; Armeni AK; Tsapanos VS; Decavalas GO; Georgopoulos NA
    Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes.
    Kowalska I; Malecki MT; Straczkowski M; Skupien J; Karczewska-Kupczewska M; Nikolajuk A; Szopa M; Adamska A; Wawrusiewicz-Kurylonek N; Wołczynski S; Sieradzki J; Gorska M
    Diabetes Metab; 2009 Sep; 35(4):328-31. PubMed ID: 19625203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Association between single nucleotide polymorphism of rs2252673 of INSR gene and polycystic ovarian syndrome].
    Du J; Wang Z; Zhang J; Jia L; Zhang F; Shi Y; Chen Z
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):919-24. PubMed ID: 25608993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine signal suppressor (SOCS) 1-1478 CA/del gene polymorphism in Turkish patients with polycystic ovary syndrome.
    Oz Gul O; Cander S; Gul CB; Budak F; Oral B; Ersoy C
    J Obstet Gynaecol; 2017 Oct; 37(7):896-901. PubMed ID: 28569589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women.
    Shaikh N; Dadachanji R; Meherji P; Shah N; Mukherjee S
    Gene; 2016 Feb; 577(2):180-6. PubMed ID: 26625974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission ratio distortion at the INS-IGF2 VNTR.
    Eaves IA; Bennett ST; Forster P; Ferber KM; Ehrmann D; Wilson AJ; Bhattacharyya S; Ziegler AG; Brinkmann B; Todd JA
    Nat Genet; 1999 Aug; 22(4):324-5. PubMed ID: 10431232
    [No Abstract]   [Full Text] [Related]  

  • 36. The influence of INS VNTR class III allele on auxological parameters, glucose, insulin, lipids, and adipocytokines secretion in prepubertal children born small for gestational age.
    Stawerska R; Szałapska M; Borowiec M; Antosik K; Młynarski W; Lewiński A
    Endokrynol Pol; 2016; 67(6):585-591. PubMed ID: 28042651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta cell function and insulin sensitivity in women with polycystic ovary syndrome: influence of the family history of type 2 diabetes mellitus.
    Vrbikova J; Bendlova B; Vankova M; Dvorakova K; Grimmichova T; Vondra K; Pacini G
    Gynecol Endocrinol; 2009 Sep; 25(9):597-602. PubMed ID: 19572227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INS VNTR allelic variation and dynamic insulin secretion in healthy adult non-diabetic Caucasian subjects.
    Ahmed S; Bennett ST; Huxtable SJ; Todd JA; Matthews DR; Gough SC
    Diabet Med; 1999 Nov; 16(11):910-7. PubMed ID: 10588520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common variants of transcription factor 7-like 2 (TCF7L2) are associated with reduced insulin secretion in women with polycystic ovary syndrome.
    Liu B; Lv HM; Li LN; Xia L; Zhang HX; Zhang YJ; Lei L
    Gynecol Endocrinol; 2012 Aug; 28(8):594-7. PubMed ID: 22296403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Interrelationship of abnormal family history in the first degree relatives and clinical phenotype of patients with polycystic ovary syndrome].
    Wang Y; Mao WW; Chen YJ; Li MZ; Qiao J; Wang LN
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):756-60. PubMed ID: 18307903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.